Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC is intensifying regulatory oversight of pharmaceuticals and clinical trials through new mandatory training, a pharmacist reserve corps, and blacklisting/watchlisting of non-compliant products and companies. For Nigerian SMBs in healthcare, pharma distribution, and related sectors, this means stricter compliance requirements, supply chain scrutiny, and potential disruptions if sourcing from flagged entities. Businesses should verify product authenticity, update regulatory knowledge, and prepare for increased enforcement.
Pharmaceuticals and Healthcare
Importation and Distribution
Clinical Research
Retail and PPMVs
Export and Agriculture (Fish Farming)
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria
NAFDAC
NAFDAC and NHREC have rescheduled mandatory training on clinical trial regulations for stakeholders in Nigeria.
SMBs involved in clinical trials or pharmaceutical research must attend to remain compliant; non-attendance may affect licensing or trial approvals.
Public Notice on Blacklisting Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC has blacklisted Ayrtons Saunders Ltd, UK, and its products, warning importers, distributors, and healthcare institutions.
SMBs importing or distributing Ayrtons Saunders products must immediately cease and verify supply chains to avoid regulatory penalties and product seizure.
Public Alert No. 043/2026-NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist Pending Regulatory Investigation
NAFDAC
NAFDAC has placed products marketed by Mofus Nigeria Ltd on a watchlist pending investigation, alerting healthcare professionals and retailers.
SMBs selling or distributing Mofus products should quarantine them and await further regulatory guidance to avoid liability.
Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated a Pharmacist Reserve Group of 600 pharmacists for voluntary service to enhance regulatory capacity.
SMBs may benefit from increased regulatory support and faster service, but should also expect more rigorous inspections and compliance checks.
Address by Prof. Mojisola Christianah Adeyeye at the 49th Annual International Conference of the Chemical Society of Nigeria
NAFDAC
NAFDAC DG highlighted innovations in medicinal and pharmaceutical chemistry for affordable healthcare delivery.
SMBs in pharma manufacturing and chemistry should watch for new regulatory pathways and incentives for local production and innovation.
Regulatory and Supervisory Guidelines for Bureau De Change Operations in Nigeria 2024
Other
New regulatory and supervisory guidelines for Bureau De Change operations in Nigeria were published.
SMBs in the financial services sector, especially BDCs, must comply with updated CBN guidelines to avoid sanctions.
NDLEA, NAFDAC exempted from dissolution of FG parastatals boards
NAFDAC
NAFDAC and NDLEA were exempted from the dissolution of federal parastatal boards, ensuring continuity.
SMBs relying on NAFDAC for regulatory approvals can expect stability in leadership and ongoing operations.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
Other
Guide on registering fish farms with NEPC for export purposes.
SMBs in aquaculture and fish farming can leverage this guide to access export markets and comply with NEPC requirements.
Increased NAFDAC enforcement on product safety and clinical trials may disrupt supply chains for non-compliant SMBs.
Blacklisting and watchlisting of specific companies signal need for rigorous supplier due diligence.
Mandatory training for clinical trials indicates tighter regulation of research and development activities.
Pharmacist Reserve Group may lead to more frequent inspections and faster regulatory processes.
Focus on local pharmaceutical innovation could create opportunities for SMBs in manufacturing and chemistry.
Bureau De Change guidelines affect financial SMBs, requiring updated compliance.
NAFDAC's stability ensures consistent regulatory environment for health-related SMBs.
NEPC fish farm registration guide opens export opportunities for agribusiness SMBs.
1
Verify all pharmaceutical products and suppliers against NAFDAC blacklists and watchlists.
2
Register and attend NAFDAC/NHREC mandatory clinical trial training if involved in research.
3
Review and update internal quality control and procurement procedures to align with NAFDAC alerts.
4
For BDC operators, obtain and study the 2024 CBN Regulatory Guidelines and adjust operations accordingly.
5
Fish farmers should initiate NEPC registration to access export markets.
6
Stay informed via NAFDAC and other regulatory websites for updates on product safety and compliance deadlines.
7
Conduct staff training on regulatory changes and ethical practices.
8
Engage with industry associations for collective compliance and advocacy.